Peter H. Gough
Vice-President, Principal Consultant
NSF - Life sciences
Peter is a specialist in EU and UK legislation and guidance that impacts on the manufacture and distribution of medicinal products. He is a chemist with a Master’s degree in analytical chemistry and over 50 years’ experience of pharmaceutical manufacture, control and quality management. In 2016 he received an honorary Doctor of Science degree from Kingston University, London, for services to pharmaceutical quality management. In 2025 he was awarded the “Outstanding Contribution Award” from the conference on Making and Distributing Pharmaceuticals.
He worked for 30 years in various capacities at Eli Lilly before coming to NSF in 2005, where he retired as Senior Quality Consultant in Eli Lilly’s Global Quality Systems division. His experience is extensive, especially in quality control laboratories and in the manufacture of solid dosage forms and small molecule active pharmaceutical ingredients.
Peter has a wealth of experience in European pharmaceutical legislation and guidance and extensive experience in defining quality systems at a global level. He is a former member of the European Federation of Pharmaceutical Industry Association’s (EFPIA) Manufacturing and GMP ad hoc group and was EFPIA topic leader on the ICH Q9 Expert Working Group that developed the original 2005 guideline on Quality Risk Management. In 2011, he received the “Leveraging Collaboration Award” from the US FDA for his contribution to the on-line ICH Q9 briefing pack.
Peter is a recognised expert on the role of the Qualified Person (QP) having been eligible to act as a QP since 1985. He is a former chair of the Royal Society of Chemistry’s Qualified Person Assessor panel.
He is a Fellow of the Royal Society of Chemistry and the UK Chartered Quality Institute (CQI). He was the former chairman and life-member of the CQI’s Pharmaceutical Quality Group. For many years Peter has been a champion of the application of statistical data analysis techniques to support continual improvement within pharmaceutical quality management systems.
He is an Honorary Lecturer in the Department of Pharmaceutical Quality Management and GMP at the University of Strathclyde.
